Joint Filing Agreement
Exhibit 99.1
The undersigned hereby agree that the Statement on Amendment No. 1 to Schedule 13G dated February 17, 2015 with respect to the shares of Common Stock of Five Prime Therapeutics, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Dated: February 17, 2015
|
BIOTECHNOLOGY VALUE FUND, L.P.
|
INVESTMENT 10, L.L.C.
|
|||
|
|
||||
|
By:
|
BVF Partners L.P., its general partner
|
By:
|
BVF Partners L.P., its investment adviser
|
|
|
By:
|
BVF Inc., its general partner
|
By:
|
BVF Inc., its general partner
|
|
|
|
|
|||
|
By:
|
/s/ Xxxx X. Xxxxxxx
|
By:
|
/s/ Xxxx X. Xxxxxxx
|
|
|
Xxxx X. Xxxxxxx
|
Xxxx X. Xxxxxxx
|
|||
|
President
|
President
|
|||
|
|
||||
|
|
||||
|
BIOTECHNOLOGY VALUE FUND II, L.P.
|
MSI BVF SPV, LLC
|
|||
|
|
||||
|
By:
|
BVF Partners L.P., its general partner
|
By:
|
BVF Partners L.P., its investment adviser
|
|
|
By:
|
BVF Inc., its general partner
|
By:
|
BVF Inc., its general partner
|
|
|
|
|
|||
|
By:
|
/s/ Xxxx X. Xxxxxxx
|
By:
|
/s/ Xxxx X. Xxxxxxx
|
|
|
Xxxx X. Xxxxxxx
|
Xxxx X. Xxxxxxx
|
|||
|
President
|
President
|
|||
|
|
|
|||
|
|
||||
|
BVF PARTNERS L.P.
|
BVF INC.
|
|||
|
|
|
|||
|
By:
|
BVF Inc., its general partner
|
By:
|
/s/ Xxxx X. Xxxxxxx
|
|
|
Xxxx X. Xxxxxxx
|
||||
|
By:
|
/s/ Xxxx X. Xxxxxxx
|
President
|
||
|
Xxxx X. Xxxxxxx
|
|
|||
|
President
|
|
|||
|
|
/s/ Xxxx X. Xxxxxxx
|
|||
|
|
XXXX X. XXXXXXX
|
|||
